Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Regulatory Affairs
Return to: PBR Home | Regulatory Affairs | Suppliers

NSF Regulatory Radar: 21st Century Cures Act, Promoting Innovation

Published 23 May 2017 | By NSF Health Sciences Pharma Biotech PBR

The Cures Act aims to promote Drug Development Tools and Continuous Manufacturing innovations to speed up and enhance the development process of new therapeutics and reduce the failure rate by formalizing them within the regulatory framework.

Learn more on this topic from our Regulatory experts Marinka Tellier, Director of Regulatory Affairs at NSF International and Andy Papas, VP of Regulatory Affairs at NSF International - Read the full article